AGEs |
Advanced glycation end products |
AL |
Axial length |
AMD |
Age-related macular degeneration |
BDNF |
Brain-derived neurotrophic factor |
COX-2 |
Cyclooxygenase-2 |
CRN |
Council for Responsible Nutrition |
DR |
Diabetic retinopathy |
ERG |
Electroretinogram |
ERK |
Extracellular signal-regulated kinase |
FDA |
US Food and Drug Administration |
GGPP |
Geranylgeranyl pyrophosphate |
GPx |
Glutathione peroxidase |
GRAS |
Generally Regarded as Safe |
GSH |
Glutathione |
HbA1c |
Hemoglobin A1c |
HDL |
High-density lipoproteins |
IGF-1 |
Insulin-like growth factor-1 |
IL-1β |
Interleukin 1β |
iNOS |
Inducible nitric oxide synthase |
IRMA |
Intraretinal microvascular abnormalities |
LASIK |
Laser Assisted in situ Keratomileusis |
LDL |
Low-density lipoproteins |
mfERG |
Multifocal electroretinography |
MPOD |
Macular pigment optical density |
NF-κB |
Nuclear factor-kappa B |
NPDR |
Non-proliferative diabetic retinopathy |
OCT |
Optical coherence tomography |
OIR |
Oxygen-Induced Retinopathy |
PDR |
Proliferative diabetic retinopathy |
ROP |
Retinopathy of prematurity |
ROS |
Reactive oxygen species |
RPE |
Retinal pigment epithelium |
SMILE |
Small Incision Lenticule Extraction |
VLDL |
Very-low-density lipoproteins |